Published September 2021 | Version v1
Journal article

Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study

  • 1. Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
  • 2. Department of Radiology, Kyung Hee University Seoul Hospital, Seoul, South (Korea, Republic of)
  • 3. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South (Korea, Republic of)
  • 4. Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, South (Korea, Republic of)
  • 5. Department of Radiology, Soonchunhyang University Hospital, Bucheon, South (Korea, Republic of)
  • 6. Department of Radiology, Pusan National University Yangsan Hospital, Yangsan, South (Korea, Republic of)
  • 7. Department of Radiology, Daegu Catholic University Medical Center, Daegu, South (Korea, Republic of)

Description

Highlights: • A rebleeding rate of 9.6% was observed in patients with HCC who underwent RTO. • New or worsening ascites and esophageal varices were observed in 16.4% and 17.8%. • Macrovascular invasion and HRS were independent negative predictors of survival. To evaluate the effectiveness and safety of retrograde transvenous obliteration (RTO) for the prevention of variceal rebleeding variceal rebleeding in patients with hepatocellular carcinoma (HCC).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.crad.2021.05.011

Additional details

Identifiers

DOI
10.1016/j.crad.2021.05.011;
PII
S0009926021002695;

Publishing Information

Journal Title
Clinical Radiology
Journal Volume
76
Journal Issue
9
Journal Page Range
p. 681-687
ISSN
0009-9260
CODEN
CLRAAG

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53113197
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ASCITES; ESOPHAGUS; HEPATOMAS; PATIENTS
Descriptors DEC
BODY; CARCINOMAS; DIGESTIVE SYSTEM; DISEASES; NEOPLASMS; ORGANS; PATHOLOGICAL CHANGES; SYMPTOMS

Optional Information

Copyright
Copyright (c) 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.